Professional Overview

Subhan Mian is a seasoned regulatory affairs professional currently serving as Associate Director Regulatory Affairs. His expertise spans global regulatory affairs strategy, early-stage drug development, and oncology, with a strong focus on the pharmaceutical industry.

Experience Summary

Current Role

Subhan Mian is currently holds multiple roles including Volunteer at Halloran Consulting Group, Inc., Associate Director Regulatory Affairs at Bristol Myers Squibb, Founder at PharmaPath Consulting, LLC., Associate Director, Global Regulatory Affairs Strategy at Syneos Health, and Senior Manager, Global Regulatory Affairs Strategy at Jiangsu Hengrui Pharmaceuticals Co., Ltd. His key responsibilities include developing and implementing regulatory strategies, collaborating with cross-functional teams, and ensuring compliance with regulatory requirements.

Career Progression

Subhan Mian's career progression is marked by notable roles in regulatory affairs, including Senior Manager, Global Regulatory Affairs Strategy, and Associate Director, Global Regulatory Affairs Strategy. His career trajectory demonstrates growth and expertise in regulatory affairs, with a focus on oncology, hematology, and rare diseases.

Areas of Expertise

Subhan Mian's areas of expertise include:
Global regulatory affairs strategy
Early-stage drug development
Oncology, hematology, and rare diseases
Leadership and management capabilities
* Technical competencies in regulatory affairs

Professional Impact

Subhan Mian's professional impact is evident in his current roles and responsibilities, where he is driving regulatory strategies and ensuring compliance with regulatory requirements. His expertise and contributions have significant implications for the pharmaceutical industry, particularly in the areas of oncology, hematology, and rare diseases.

Conclusion

Subhan Mian's professional trajectory is marked by significant growth, expertise, and contributions to the pharmaceutical industry. His current focus on regulatory affairs, combined with his leadership and management capabilities, positions him as a valuable asset to his organizations. His value proposition lies in his ability to develop and implement effective regulatory strategies, drive compliance, and contribute to the advancement of the pharmaceutical industry.